{"title":"新型抗精神病药物卡里吡嗪专利分析","authors":"Naiyan Shi","doi":"10.3760/CMA.J.ISSN.1006-1924.2019.03.008","DOIUrl":null,"url":null,"abstract":"Objective \nCariprazine is the first orally active dopamine D3-preferring D3/D2 receptor partial agonist as antipsychotic agents. It receives a lot of concern for its remarkable efficacy and broad market prospect. In this article, overall application status of cariprazine patent, which includes the patent application quantity, applicants and technical topics, as well as possible technical obstacles were statistically analyzed. \n \n \nMethods \nThe patent quantitative analysis method was used, combing with pharmacy expertise, to analyze the patent application situation at home and abroad. \n \n \nResults \nThe patent technology of cariprazine involves product, process, new use, component of combination, formulation and general interest. \n \n \nConclusions \nThe concern of patent situation for cariprazine was high. Patents about different salt and its crystal, analytical method and impurities should be dug up by domestic generic pharmaceutical enterprises for further generic drug development considering the existing technology barrier. \n \n \nKey words: \nSchizophrenia; Cariprazine; Patent; Analysis","PeriodicalId":59555,"journal":{"name":"中华医学科研管理杂志","volume":"32 1","pages":"193-198"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patent analysis on Cariprazine: A novel antipsychotic agent\",\"authors\":\"Naiyan Shi\",\"doi\":\"10.3760/CMA.J.ISSN.1006-1924.2019.03.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nCariprazine is the first orally active dopamine D3-preferring D3/D2 receptor partial agonist as antipsychotic agents. It receives a lot of concern for its remarkable efficacy and broad market prospect. In this article, overall application status of cariprazine patent, which includes the patent application quantity, applicants and technical topics, as well as possible technical obstacles were statistically analyzed. \\n \\n \\nMethods \\nThe patent quantitative analysis method was used, combing with pharmacy expertise, to analyze the patent application situation at home and abroad. \\n \\n \\nResults \\nThe patent technology of cariprazine involves product, process, new use, component of combination, formulation and general interest. \\n \\n \\nConclusions \\nThe concern of patent situation for cariprazine was high. Patents about different salt and its crystal, analytical method and impurities should be dug up by domestic generic pharmaceutical enterprises for further generic drug development considering the existing technology barrier. \\n \\n \\nKey words: \\nSchizophrenia; Cariprazine; Patent; Analysis\",\"PeriodicalId\":59555,\"journal\":{\"name\":\"中华医学科研管理杂志\",\"volume\":\"32 1\",\"pages\":\"193-198\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华医学科研管理杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1006-1924.2019.03.008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华医学科研管理杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-1924.2019.03.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Patent analysis on Cariprazine: A novel antipsychotic agent
Objective
Cariprazine is the first orally active dopamine D3-preferring D3/D2 receptor partial agonist as antipsychotic agents. It receives a lot of concern for its remarkable efficacy and broad market prospect. In this article, overall application status of cariprazine patent, which includes the patent application quantity, applicants and technical topics, as well as possible technical obstacles were statistically analyzed.
Methods
The patent quantitative analysis method was used, combing with pharmacy expertise, to analyze the patent application situation at home and abroad.
Results
The patent technology of cariprazine involves product, process, new use, component of combination, formulation and general interest.
Conclusions
The concern of patent situation for cariprazine was high. Patents about different salt and its crystal, analytical method and impurities should be dug up by domestic generic pharmaceutical enterprises for further generic drug development considering the existing technology barrier.
Key words:
Schizophrenia; Cariprazine; Patent; Analysis
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
